Ad is loading...
BEAM
Price
$23.58
Change
-$0.91 (-3.72%)
Updated
Nov 21 closing price
102 days until earnings call
OCUL
Price
$8.52
Change
-$0.26 (-2.96%)
Updated
Nov 21 closing price
104 days until earnings call
Ad is loading...

BEAM vs OCUL

Header iconBEAM vs OCUL Comparison
Open Charts BEAM vs OCULBanner chart's image
Beam Therapeutics
Price$23.58
Change-$0.91 (-3.72%)
Volume$1.01M
CapitalizationN/A
Ocular Therapeutix
Price$8.52
Change-$0.26 (-2.96%)
Volume$1.09M
CapitalizationN/A
BEAM vs OCUL Comparison Chart
Loading...
BEAM
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
OCUL
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
BEAM vs. OCUL commentary
Nov 22, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BEAM is a StrongBuy and OCUL is a Hold.

COMPARISON
Comparison
Nov 22, 2024
Stock price -- (BEAM: $23.58 vs. OCUL: $8.52)
Brand notoriety: BEAM and OCUL are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BEAM: 94% vs. OCUL: 86%
Market capitalization -- BEAM: $2.03B vs. OCUL: $1.38B
BEAM [@Biotechnology] is valued at $2.03B. OCUL’s [@Biotechnology] market capitalization is $1.38B. The market cap for tickers in the [@Biotechnology] industry ranges from $463.61B to $0. The average market capitalization across the [@Biotechnology] industry is $2.63B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BEAM’s FA Score shows that 0 FA rating(s) are green whileOCUL’s FA Score has 0 green FA rating(s).

  • BEAM’s FA Score: 0 green, 5 red.
  • OCUL’s FA Score: 0 green, 5 red.
According to our system of comparison, OCUL is a better buy in the long-term than BEAM.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BEAM’s TA Score shows that 3 TA indicator(s) are bullish while OCUL’s TA Score has 5 bullish TA indicator(s).

  • BEAM’s TA Score: 3 bullish, 6 bearish.
  • OCUL’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, OCUL is a better buy in the short-term than BEAM.

Price Growth

BEAM (@Biotechnology) experienced а -10.38% price change this week, while OCUL (@Biotechnology) price change was -14.11% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.14%. For the same industry, the average monthly price growth was -4.98%, and the average quarterly price growth was +4.01%.

Reported Earning Dates

BEAM is expected to report earnings on Mar 04, 2025.

OCUL is expected to report earnings on Mar 06, 2025.

Industries' Descriptions

@Biotechnology (+2.14% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BEAM($2.03B) has a higher market cap than OCUL($1.38B). OCUL YTD gains are higher at: 91.031 vs. BEAM (-13.373). OCUL (-155.92M) and BEAM (-160.83M) have comparable annual earnings (EBITDA) . BEAM has more cash in the bank: 926M vs. OCUL (427M). OCUL has less debt than BEAM: OCUL (75.1M) vs BEAM (162M). BEAM has higher revenues than OCUL: BEAM (350M) vs OCUL (61.4M).
BEAMOCULBEAM / OCUL
Capitalization2.03B1.38B147%
EBITDA-160.83M-155.92M103%
Gain YTD-13.37391.031-15%
P/E RatioN/AN/A-
Revenue350M61.4M570%
Total Cash926M427M217%
Total Debt162M75.1M216%
FUNDAMENTALS RATINGS
OCUL: Fundamental Ratings
OCUL
OUTLOOK RATING
1..100
57
VALUATION
overvalued / fair valued / undervalued
1..100
47
Fair valued
PROFIT vs RISK RATING
1..100
73
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
37
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
95

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BEAMOCUL
RSI
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 2 days ago
71%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
86%
Momentum
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
78%
MACD
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
83%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
88%
Advances
ODDS (%)
Bullish Trend 4 days ago
81%
Bullish Trend 17 days ago
84%
Declines
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
82%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
83%
Bullish Trend 2 days ago
83%
Aroon
ODDS (%)
N/A
Bullish Trend 2 days ago
89%
View a ticker or compare two or three
Ad is loading...
BEAM
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
OCUL
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GLNMX23.870.25
+1.06%
MFS Global New Discovery R4
CVTRX51.060.22
+0.43%
Calamos Growth & Income A
HGHVX47.230.20
+0.43%
Hartford Healthcare R6
FPUKX25.450.09
+0.35%
Fidelity Puritan K
FEQZX13.29N/A
N/A
Fidelity Advisor Hedged Equity Fund Z

OCUL and

Correlation & Price change

A.I.dvisor indicates that over the last year, OCUL has been loosely correlated with EYPT. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if OCUL jumps, then EYPT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OCUL
1D Price
Change %
OCUL100%
-2.96%
EYPT - OCUL
49%
Loosely correlated
-6.76%
RCUS - OCUL
44%
Loosely correlated
-2.33%
PLRX - OCUL
41%
Loosely correlated
+0.94%
RXRX - OCUL
39%
Loosely correlated
-4.80%
BEAM - OCUL
39%
Loosely correlated
-3.72%
More